Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone

Neuroscience Research

Volumn 69, Issue 1, 2011, Pages 41-50

  Paterson, Neil E ^a   Ricciardi, Jennifer ^a   Wetzler, Caitlin ^a   Hanania, Taleen ^a  

^a PSYCHOGENICS INC   (United States)

Author keywords

5 CSRTT; Atomoxetine; Attention; D Amphetamine; Impulsivity; Methylphenidate; Rat; Tolcapone; Variable inter trial interval

Indexed keywords

AMPHETAMINE; ATOMOXETINE; DOPAMINE; METHYLPHENIDATE; NORADRENALIN; TOLCAPONE;

ANIMAL MODEL; ARTICLE; ATTENTION; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; FRONTAL CORTEX; IMPULSIVENESS; MALE; MENTAL PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; REACTION TIME;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ATTENTION; BENZOPHENONES; CATECHOL O-METHYLTRANSFERASE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOICE BEHAVIOR; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMPULSIVE BEHAVIOR; MALE; METHYLPHENIDATE; NITROPHENOLS; NOREPINEPHRINE; PREFRONTAL CORTEX; PROPYLAMINES; RATS; RATS, LONG-EVANS; REACTION TIME;

EID: 78649861264     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2010.10.001     Document Type: Article

References (48)

1. Acquas E., Carboni E., de Ree R.H., Da Prada M., Di Chiara G. Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592. J. Neurochem. 1992, 59:326-330.
2. Arnsten A.F. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs 2009, 23:33-41.
3. Bari A., Dalley J.W., Robbins T.W. The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat. Protoc. 2008, 3:759-767.
4. Biederman J., Melmed R.D., Patel A., McBurnett K., Donahue J., Lyne A. Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr. 2008, 13:1047-1055.
5. Bizarro L., Patel S., Murtagh C., Stolerman I.P. Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate. Behav. Pharmacol. 2004, 15:195-206.
6. Blondeau C., Dellu-Hagedorn F. Dimensional analysis of ADHD subtypes in rats. Biol. Psychiatry 2007, 61:1340-1350.
7. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., Morin S.M., Gehlert D.R., Perry K.W. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002, 27:699-711.
8. Carboni E., Tanda G.L., Frau R., Di Chiara G. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 1990, 55:1067-1070.
9. Chamberlain S.R., Del Campo N., Dowson J., Müller U., Clark L., Robbins T.W., Sahakian B.J. Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol. Psychiatry 2007, 62:977-984.
10. Cole B.J., Robbins T.W. Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology 1987, 91:458-466.
11. Dalley J.W., McGaughy J., O'Connell M.T., Cardinal R.N., Levita L., Robbins T.W. Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task. J. Neurosci. 2001, 21:4908-4914.
12. Dalley J.W., Theobald D.E., Pereira E.A., Li P.M., Robbins T.W. Specific abnormalities in serotonin release in the prefrontal cortex of isolation-reared rats measured during behavioural performance of a task assessing visuospatial attention and impulsivity. Psychopharmacology 2002, 164:329-340.
13. Day M., Pan J.B., Buckley M.J., Cronin E., Hollingsworth P.R., Hirst W.D., Navarra R., Sullivan J.P., Decker M.W., Fox G.B. Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test. Biochem. Pharmacol. 2007, 73:1123-1134.
14. de Wit H., Enggasser J.L., Richards J.B. Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 2002, 27(5):813-825.
15. Dow-Edwards D.L., Weedon J.C., Hellmann E. Methylphenidate improves performance on the radial arm maze in periadolescent rats. Neurotoxicol. Teratol. 2008, 30:419-427.
16. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. USA 1998, 95:9991-9996.
17. Granon S., Passetti F., Thomas K.L., Dalley J.W., Everitt B.J., Robbins T.W. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J. Neurosci. 2000, 20:1208-1215.
18. Gresch P.J., Sved A.F., Zigmond M.J., Finlay J.M. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J. Neurochem. 1995, 65:111-116.
19. Grottick A.J., Haman M., Wyler R., Higgins G.A. Reversal of a vigilance decrement in the aged rat by subtype-selective nicotinic ligands. Neuropsychopharmacology 2003, 28:880-887.
20. Han D.D., Gu H.H. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. B. M. C. Pharmacol. 2006, 6:6.
21. Harrison A.A., Everitt B.J., Robbins T.W. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology 1997, 133:329-342.
22. Higgins G.A., Grzelak M.E., Pond A.J., Cohen-Williams M.E., Hodgson R.A., Varty G.B. The effect of caffeine to increase reaction time in the rat during a test of attention is mediated through antagonism of adenosine A2A receptors. Behav. Brain Res. 2007, 185:32-42.
23. Holmes J.C., Rutledge C.O. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain. Biochem. Pharmacol. 1976, 25(4):447-451.
24. Jentsch J.D. Impaired visuospatial divided attention in the spontaneously hypertensive rat. Behav. Brain Res. 2005, 157(2):323-330.
25. Kantak K.M., Singh T., Kerstetter K.A., Dembro K.A., Mutebi M.M., Harvey R.C., Deschepper C.F., Dwoskin L.P. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder. Behav. Neurosci. 2008, 122:340-357.
26. Lapish C.C., Ahn S., Evangelista L.M., So K., Seamans J.K., Phillips A.G. Tolcapone enhances food-evoked dopamine efflux and executive memory processes mediated by the rat prefrontal cortex. Psychopharmacology 2009, 202:521-530.
27. Lee J., Park S. The role of stimulus salience in CPT-AX performance of schizophrenia patients. Schizophr. Res. 2006, 81:191-197.
28. Levinoff E.J., Phillips N.A., Verret L., Babins L., Kelner N., Akerib V., Chertkow H. Cognitive estimation impairment in Alzheimer disease and mild cognitive impairment. Neuropsychology 2006, 20:123-132.
29. Michelson D., Adler L., Spencer T., Reimherr F.W., West S.A., Allen A.J., Kelsey D., Wernicke J., Dietrich A., Milton D. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol. Psychiatry 2003, 53:112-120.
30. Milstein J., Dalley J., Robbins T. Methylphenidate-induced impulsivity: pharmacological antagonism by beta-adrenoreceptor blockade. J. Psychopharmacol. 2010, 24(3):309-321.
31. Napolitano A., Bellini G., Borroni E., Zürcher G., Bonuccelli U. Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats. Parkinsonism Relat. Disord. 2003, 9:145-150.
32. National Institutes of Health Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, DC.
33. Navarra R., Graf R., Huang Y., Logue S., Comery T., Hughes Z., Day M. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:34-41.
34. Paine T.A., Tomasiewicz H.C., Zhang K., Carlezon W.A. Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats. Biol. Psychiatry 2007, 62:687-693.
35. Puumala T., Ruotsalainen S., Jäkälä P., Koivisto E., Riekkinen P., Sirviö J. Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder. Neurobiol. Learn. Mem. 1996, 66:198-211.
36. Riccio C.A., Waldrop J.J., Reynolds C.R., Lowe P. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J. Neuropsychiatry Clin. Neurosci. 2001, 13:326-335.
37. Robbins T.W. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 2002, 163:362-380.
38. Robinson E.S., Eagle D.M., Mar A.C., Bari A., Banerjee G., Jiang X., Dalley J.W., Robbins T.W. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 2008, 33:1028-1037.
39. Sagvolden T. The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD). Behav. Brain Funct. 2006, 2:41.
40. Semenova S., Stolerman I.P., Markou A. Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats. Pharmacol. Biochem. Behav. 2007, 87:360-368.
41. Seu E., Lang A., Rivera R.J., Jentsch J.D. Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys. Psychopharmacology 2009, 202:505-519.
42. Swanson C.J., Perry K.W., Koch-Krueger S., Katner J., Svensson K.A., Bymaster F.P. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology 2006, 50:755-760.
43. Tsutsui-Kimura I., Ohmura Y., Izumi T., Yamaguchi T., Yoshida T., Yoshioka M. The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats. Behav. Pharmacol. 2009, 20:474-483.
44. Tunbridge E.M., Bannerman D.M., Sharp T., Harrison P.J. Catechol-O-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J. Neurosci. 2004, 24:5331-5335.
45. van Gaalen M.M., Brueggeman R.J., Bronius P.F., Schoffelmeer A.N., Vanderschuren L.J. Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology 2006, 187:73-85.
46. Wong D.T., Threlkeld P.G., Best K.L., Bymaster F.P. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. J. Pharmacol. Exp. Ther. 1982, 222:61-65.
47. Yamamoto B.K., Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. J. Neurochem. 1998, 71:274-280.
48. Zürcher G., Keller H.H., Kettler R., Borgulya J., Bonetti E.P., Eigenmann R., Da Prada M. Ro 40-7592 a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats. Adv. Neurol. 1990, 53:497-503.